Emergent Biosolutions Inc (EBS) : Eqis Capital Management reduced its stake in Emergent Biosolutions Inc by 14.13% during the most recent quarter end. The investment management company now holds a total of 51,760 shares of Emergent Biosolutions Inc which is valued at $1,668,225 after selling 8,518 shares in Emergent Biosolutions Inc , the firm said in a disclosure report filed with the SEC on Oct 4, 2016.Emergent Biosolutions Inc makes up approximately 0.10% of Eqis Capital Management’s portfolio.

Emergent Biosolutions Inc closed down -0.07 points or -0.22% at $31.55 with 5,92,460 shares getting traded on Tuesday. Post opening the session at $31.79, the shares hit an intraday low of $31.1 and an intraday high of $31.99 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Emergent Biosolutions Inc reported $-0.27 EPS for the quarter, missing the analyst consensus estimate by $ -0.10 based on the information available during the earnings call on Aug 4, 2016. Analyst had a consensus of $-0.17. The company had revenue of $101.49 million for the quarter, compared to analysts expectations of $111.12 million. The company’s revenue was down -19.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.36 EPS.